Granulocyte-macrophage-colony-stimulating factor
Jump to navigation
Jump to search
| Granulocyte-macrophage-colony-stimulating factor | |
|---|---|
| Term | Granulocyte-macrophage-colony-stimulating factor |
| Short definition | granulocyte colony stimulating factor (GRAN-yoo-loh-SITE KAH-luh-nee-STIM-yoo-LAY-ting FAK-ter) A drug sold under the brand names Neupogen, Zarxio and Nivestym is used to treat neutropenia (a lower than normal white blood cell count), prevent infections and prepare the blood for drawing certain types of blood cells, and under the brand name Granix, to treat neutropenia. Granulocyte colony stimulating factor is used in patients with certain types of cancer and neutropenia caused by some types of chemotherapy and in patients with severe chronic neutropenia not caused by cancer treatment. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
granulocyte-macrophage-colony-stimulating factor - (pronounced) (GRAN-yoo-loh-SITE-MA-kroh-FAYJ KAH-luh-nee-STIM-yoo-LAY-ting FAK-ter) A Substance that helps produce more white blood cells, especially granulocytes, macrophages and cells that become platelets. It is a cytokine that is a type of hematopoietic (blood-forming) agent. Also called GM-CSF and Sargramostim
External links
- Medical encyclopedia article on Granulocyte-macrophage-colony-stimulating factor
- Wikipedia's article - Granulocyte-macrophage-colony-stimulating factor
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski